Descovy

Descovy (emtricitabine/tenofovir alafenamide) is a prescription medication used to treat HIV treatment and prevention (PrEP). A once-daily pill used as part of HIV treatment and for HIV pre-exposure prophylaxis (PrEP) in certain at-risk adults and adolescents.

Two NRTIs that block the enzyme HIV needs to multiply, lowering the amount of virus in the body.

Commonly reported side effects of Descovy include Diarrhea, Nausea, Headache, Worsening of hepatitis B if stopped (boxed warning), and Not for all PrEP populations. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Yes. Descovy carries an FDA Boxed Warning — the agency's most serious safety warning. Read the full prescribing information and talk to your doctor about the risks before starting or changing treatment.

The active ingredient in Descovy is emtricitabine/tenofovir alafenamide, which belongs to a class of medicines known as NRTI Combination.

Descovy is manufactured by Gilead Sciences. It was first approved in 2016.

You may be able to lower the cost of Descovy by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.